Spruce Street Capital LP 13F Portfolio
| Entity | Category | QoQ AUM Change | AUM (13F) | # of Holdings | Performance Rank | Equities Trend |
|---|---|---|---|---|---|---|
SS Spruce Street Capital LP | Institutional Filer | ▲ 37.43% | $415.9M | 28 |
Current Portfolio Holdings
Showing all 28 reported positions by value
| # | Stock | Company Name | Sector | Shares Held | Market Value | % of Portfolio |
|---|---|---|---|---|---|---|
| 1 | RLMD | Relmada Therapeutics, Inc. | Healthcare | 6.3M | $43.0M | 10.34% |
| 2 | KNSA | Kiniksa Pharmaceuticals, Ltd. | Healthcare | 761K | $36.6M | 8.81% |
| 3 | LBRX | LB Pharmaceuticals Inc Common Stock | Healthcare | 1.4M | $33.6M | 8.09% |
| 4 | DNTH | Dianthus Therapeutics, Inc. | Healthcare | 373K | $31.3M | 7.53% |
| 5 | RLAY | Relay Therapeutics, Inc. | Healthcare | 3.0M | $29.7M | 7.14% |
| 6 | ANRO | Alto Neuroscience, Inc. | Healthcare | 1.3M | $29.1M | 7.00% |
| 7 | CNTA | Centessa Pharmaceuticals plc | Healthcare | 490K | $19.5M | 4.68% |
| 8 | SVRA | Savara Inc. | Healthcare | 3.4M | $18.5M | 4.44% |
| 9 | KALV | KalVista Pharmaceuticals, Inc. | Healthcare | 898K | $18.1M | 4.34% |
| 10 | PCVX | Vaxcyte, Inc. | Healthcare | 246K | $14.3M | 3.43% |
| 11 | ELVN | Enliven Therapeutics, Inc. | Healthcare | 329K | $12.9M | 3.10% |
| 12 | SRZN | Surrozen, Inc. | Healthcare | 432K | $12.6M | 3.03% |
| 13 | ENTA | Enanta Pharmaceuticals, Inc. | Healthcare | 933K | $11.8M | 2.83% |
| 14 | ALKS | Alkermes plc | Healthcare | 318K | $11.2M | 2.70% |
| 15 | CATX | Perspective Therapeutics, Inc. | Healthcare | 2.6M | $11.0M | 2.63% |
Showing 1 to 15 of 28 holdings